Form4insider filings, from the source

SEC Form 4 · accession 0000919574-15-007753

MADRIGAL PHARMACEUTICALS, INC. · MDGL

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Bruce Kovner
Director · 10% Owner
Period of report
Nov 9, 2015
Accepted (ET)
Nov 12, 2015 · 5:19 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001157601

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1,F5Nov 9, 2015S2,225,054$0.6086D5,536,662IBy CxSynta LLC
Common StockF2,F5Nov 10, 2015S1,397,114$0.5505D4,139,548IBy CxSynta LLC
Common StockF3,F5Nov 11, 2015S1,080,941$0.4979D3,058,607IBy CxSynta LLC
Common StockF4,F5Nov 12, 2015S733,564$0.4741D2,325,043IBy CxSynta LLC
Common Stockholding———3,092,677D
Common StockF6holding———2,279,146IBy Wife
Common StockF7holding———11,399,464IBy KFO Holdings LLC
Common StockF8holding———5,460,000IBy OB Select Opportunities, LLC
Common Stockholding———4,000,000IBy Kovner 2015-A Investment Trust
Common Stockholding———3,100,000IBy Kovner 2012 Family Trust B

Table II — derivative securities

No Table II lines on this filing.

Explanation of responses